SEC Filing Details
Document Details
Form
Filing Date
October 16, 2026
Document Date
October 14, 2026
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Enliven Therapeutics
Issuer
ENLIVEN THERAPEUTICS, INC.
Filer
BALL KRISTINE M